Evidence map›Paper›PMID 42522023›Full record

ArticleInfectious diseases of poverty2026

Strengthening India's pandemic preparedness with the four zonal institutes of virology: stakeholder consultations for outbreak response and collaborative research priorities.

Kunal Pise, Babasaheb Tandale, Naveen Kumar, Pradip Barde, Ashok Munivenkatappa, Basavaraj Mathapati, Abhijeet Jadhav, Pankaj Rawat, Shrinivasa Basavaraj, Satish Gaikwad and 4 more

Abstract read
In one paragraph

Article in Infectious diseases of poverty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kunal PiseICMR National Institute of Virology (NIV), Microbial Containment Complex (MCC), 130/1, Sus Road, Pashan, Pune, Maharashtra, 411021, India. uknowkunal@gmail.com.
Babasaheb TandaleICMR National Institute of Virology (NIV), Microbial Containment Complex (MCC), 130/1, Sus Road, Pashan, Pune, Maharashtra, 411021, India. drtandale@gmail.com.
Naveen KumarICMR National Institute of Virology (NIV), Microbial Containment Complex (MCC), 130/1, Sus Road, Pashan, Pune, Maharashtra, 411021, India.
Pradip BardeICMR National Institute of Virology (NIV), Microbial Containment Complex (MCC), 130/1, Sus Road, Pashan, Pune, Maharashtra, 411021, India.
Ashok MunivenkatappaICMR National Institute of Virology (NIV), Microbial Containment Complex (MCC), 130/1, Sus Road, Pashan, Pune, Maharashtra, 411021, India.
Basavaraj MathapatiICMR National Institute of Virology (NIV), Microbial Containment Complex (MCC), 130/1, Sus Road, Pashan, Pune, Maharashtra, 411021, India.
Abhijeet JadhavICMR National Institute of Virology (NIV), Microbial Containment Complex (MCC), 130/1, Sus Road, Pashan, Pune, Maharashtra, 411021, India.
Pankaj RawatICMR National Institute of Translational Virology and AIDS Research, Pune, India.
Shrinivasa BasavarajNational Institute of One Health (NIOH), Nagpur, Maharashtra, India.
Satish GaikwadNational Institute of One Health (NIOH), Nagpur, Maharashtra, India.
Avinash DeoshatwarICMR National Institute of Virology (NIV), Microbial Containment Complex (MCC), 130/1, Sus Road, Pashan, Pune, Maharashtra, 411021, India.
Sakib Akther PattasseryICMR National Institute of Virology (NIV), Microbial Containment Complex (MCC), 130/1, Sus Road, Pashan, Pune, Maharashtra, 411021, India.
Susha KutteyilICMR National Institute of Virology (NIV), Microbial Containment Complex (MCC), 130/1, Sus Road, Pashan, Pune, Maharashtra, 411021, India.
Anisha PulinchaniICMR National Institute of Virology (NIV), Microbial Containment Complex (MCC), 130/1, Sus Road, Pashan, Pune, Maharashtra, 411021, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PM-ABHIM) scheme, supported by the World Bank, is establishing four zonal National Institutes of Virology (NIVs) in India. It is essential to identify the zonal disease and research priorities so as to focus research at zonal levels. This study reports a zonal viral disease prioritisation exercise to support outbreak response and collaborative research. It describes zonal-prioritised viral diseases, assesses concordance and differences in zonal priority lists and, and identifies cross‑cutting research themes and preparedness gaps using an multicriteria decision analysis (MCDA)‑based consensus process.

methodsWe conducted a cross-sectional, multi-stakeholder consultative study across four geographical zones of India in March 2024. The zonal-level consultative workshops employed a systematic consensus-building approach using the modified One Health Zoonotic Disease Prioritisation (OHZDP) tool, adapted for emerging viral diseases and applied via MCDA. We identified zonal-level stakeholders, listed 40 viral diseases and categorised them into three groups: common occurrence (Group A), limited occurrence (Group B), and rare occurrences with a chance of emergence, evolution or importation (Group C). The stakeholders from state health departments, medical colleges, research institutes and the Virus Research and Diagnostic Laboratory (VRDL) network ranked the viral diseases and research themes in each zone. Spearman rank correlation was used to assess concordance of priority rankings between zones.

resultsA total of 186 participants (42-48 per zone) contributed to the four zonal workshops including collaborators from VRDL laboratories (26%), public health stakeholders from Integrated Disease Surveillance programme(IDSP) (28%), invited experts (21%), organisers (19%) and Indian Council of Medical Research (ICMR) representatives (6%). The key outcomes included the zone-specific lists of priority viral diseases in Groups A, B and C. There were zonal variations in viral disease prioritisation, reflecting local epidemiological patterns. Spearman rank correlation analysis showed moderate positive correlation between the Central and East zones (rho = 0.697, P = 0.031), whereas other pairwise comparisons were not statistically significant, which indicated both shared and distinct priority patterns within the zones. The top five priority viral diseases across zones included dengue, influenza, measles, Japanese encephalitis and hepatitis A. The research themes and subthemes were then decided for collaborative research.

conclusionsThese multistakeholder consultations provided a novel, replicable template for prioritising viral diseases to develop strategies for mitigating the impact of future outbreaks through collaborative research. These zonal priorities may guide similar exercises at national, regional and global levels in future.

Indexed as

Disease OutbreaksVirologyVirus DiseasesAcademies and InstitutesAnimalsCross-Sectional StudiesHumansIndiaPandemic PreparednessResearchStakeholder ParticipationCollaborative researchDisease prioritisationPandemic preparednessStakeholder engagementViral diseases

Identifiers

PMID42522023
PMCPMC13411115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.